Cash Flow Statement
Growth Metrics

Biolife Solutions (BLFS) Cost of Revenue (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Cost of Revenue for 16 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue fell 88.4% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.8 million through Dec 2025, down 59.88% year-over-year, with the annual reading at $9.8 million for FY2025, 59.88% down from the prior year.
  • Cost of Revenue for Q4 2025 was $2.0 million at Biolife Solutions, down from $2.5 million in the prior quarter.
  • The five-year high for Cost of Revenue was $17.2 million in Q4 2024, with the low at -$3.9 million in Q4 2022.
  • Average Cost of Revenue over 5 years is $3.7 million, with a median of $2.9 million recorded in 2021.
  • The sharpest move saw Cost of Revenue plummeted 182.23% in 2022, then surged 1369.2% in 2024.
  • Over 5 years, Cost of Revenue stood at $4.8 million in 2021, then tumbled by 182.23% to -$3.9 million in 2022, then surged by 65.54% to -$1.4 million in 2023, then soared by 1369.2% to $17.2 million in 2024, then tumbled by 88.4% to $2.0 million in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $2.0 million, $2.5 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.